[go: up one dir, main page]

NO20006547D0 - Salts of paroxetine - Google Patents

Salts of paroxetine

Info

Publication number
NO20006547D0
NO20006547D0 NO20006547A NO20006547A NO20006547D0 NO 20006547 D0 NO20006547 D0 NO 20006547D0 NO 20006547 A NO20006547 A NO 20006547A NO 20006547 A NO20006547 A NO 20006547A NO 20006547 D0 NO20006547 D0 NO 20006547D0
Authority
NO
Norway
Prior art keywords
paroxetine
salts
Prior art date
Application number
NO20006547A
Other languages
Norwegian (no)
Other versions
NO20006547L (en
Inventor
Victor Witold Jacewicz
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20006547D0 publication Critical patent/NO20006547D0/en
Publication of NO20006547L publication Critical patent/NO20006547L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20006547A 1998-07-02 2000-12-21 Salts of paroxetine NO20006547L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (2)

Publication Number Publication Date
NO20006547D0 true NO20006547D0 (en) 2000-12-21
NO20006547L NO20006547L (en) 2001-02-12

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006547A NO20006547L (en) 1998-07-02 2000-12-21 Salts of paroxetine

Country Status (21)

Country Link
EP (1) EP1091958A1 (en)
JP (1) JP2002519421A (en)
KR (1) KR20010053337A (en)
CN (1) CN1314906A (en)
AP (1) AP2000002017A0 (en)
AU (2) AU4903999A (en)
BG (1) BG105204A (en)
BR (1) BR9911679A (en)
CA (1) CA2336470A1 (en)
CZ (1) CZ20004923A3 (en)
EA (1) EA200100098A1 (en)
GB (1) GB9814316D0 (en)
HU (1) HUP0103712A3 (en)
ID (1) ID27766A (en)
IL (1) IL140385A0 (en)
NO (1) NO20006547L (en)
PL (1) PL345365A1 (en)
SK (1) SK20242000A3 (en)
TR (1) TR200100055T2 (en)
WO (1) WO2000001692A1 (en)
ZA (2) ZA992899B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266584B1 (en) 2003-05-07 2012-09-05 Osteologix A/S Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions
PL2266585T3 (en) 2003-05-07 2013-10-31 Osteologix As Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
PL1732575T3 (en) 2004-02-26 2011-05-31 Osteologix As Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
CA2565840A1 (en) 2004-05-06 2005-11-17 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR100672184B1 (en) * 2004-09-21 2007-01-19 주식회사종근당 Choline or Choline Derivative Salts of Paroxetine
CA2672267C (en) * 2006-07-27 2016-05-31 Emisphere Technologies, Inc. Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (en) * 2018-08-19 2021-05-07 丁立平 Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water
CN109342633B (en) * 2018-11-27 2020-10-02 北京市化工职业病防治院 Method for detecting metabolites of benzene, toluene and xylene in urine
CN111337460B (en) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 High-stability Halo-tag probe and synthesis and biological application thereof
CN116283778B (en) * 2023-02-23 2025-08-29 江苏理工学院 A pyrazole carboxylic acid compound and its preparation method and application
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
SK11812000A3 (en) * 1998-02-06 2001-08-06 Smithkline Beecham Plc Salts of paroxetine

Also Published As

Publication number Publication date
NO20006547L (en) 2001-02-12
PL345365A1 (en) 2001-12-17
ZA992899B (en) 2000-03-29
GB9814316D0 (en) 1998-09-02
HUP0103712A3 (en) 2002-09-30
IL140385A0 (en) 2002-02-10
ID27766A (en) 2001-04-26
CN1314906A (en) 2001-09-26
CA2336470A1 (en) 2000-01-13
BG105204A (en) 2001-11-30
AU2002100370A4 (en) 2002-06-06
HUP0103712A2 (en) 2002-05-29
KR20010053337A (en) 2001-06-25
WO2000001692A1 (en) 2000-01-13
EP1091958A1 (en) 2001-04-18
ZA200100020B (en) 2002-03-25
JP2002519421A (en) 2002-07-02
SK20242000A3 (en) 2001-07-10
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (en) 2001-08-15
AU4903999A (en) 2000-01-24
BR9911679A (en) 2002-01-29
TR200100055T2 (en) 2001-07-23
EA200100098A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
ID27092A (en) MAKING OF ANHYDRIDAL FTALATES
CY2014027I2 (en) USE OF DIALKYLO FUMARIC ESTERS
IS2277B (en) Therapeutic baryl derivatives
FR2780269B1 (en) RACHIDIAN IMPLANT
EE200300007A (en) Heterocyclic derivatives of tetrahydropyridine or piperidine
PT1089996E (en) PAROXETINE METHOSULPHONATE
NO20011083L (en) Crystalline forms of EtOC2 - CH2 - (R) Cgl-Aze-Pab-OH
NO20006547D0 (en) Salts of paroxetine
NO20003960D0 (en) Salts of paroxetine
PT1246817E (en) DERIVATIVES OF 4-PHENYL-1-PIPERAZINYL, -PIPERIDINYL E-TETRAHYDROPYRIDYL
NO20016151D0 (en) Preparation of substituted piperidin-4-ones
ID28032A (en) TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
NO20010553L (en) Crystalline forms of osanetant
FI980222A0 (en) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
EE200100381A (en) New salts of morpholinobenzamide
PT1178984E (en) DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME
EE200100017A (en) New salts of N-tert-butylhydroxylamine
FR2802852B3 (en) PRODUCTION OF FIGURE ELEMENTS
PT1175417E (en) SUBSTITUTED COMPOUNDS OF BENZOLACTAMAS
NO20004583D0 (en) Crystalline form of paroxetine
NO20016030L (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homothylosin
NO20005683D0 (en) New formulation containing paroxetine
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN
FI980489A7 (en) New derivatives of cyclodextrins
NO20013453D0 (en) Process for the preparation of salts of cyanobenzylamines

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application